NCT06851221已完成不适用
Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma
Meyer Children's Hospital IRCCS2 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2020年8月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 95
- 试验地点
- 2
- 主要终点
- expression of beta3-adrenoreceptor
研究概览
简要总结
This study on biological samples of patients affected by neuroblastoma and Ewing sarcoma aims at validating the beta3-adrenoreceptor as prognostic biomarker.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 0 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosis of Ewing sarcoma or neuroblastoma
排除标准
- •sieropositivity
结局指标
主要结局
expression of beta3-adrenoreceptor
时间窗: from enrollment to the performance of the analysis that can take up to 6 weeks
次要结局
未报告次要终点
研究者
Maura Calvani
Head of Traslational oncoematology laboratory
Meyer Children's Hospital IRCCS
研究点 (2)
Loading locations...
相似试验
撤回
不适用
Neuroendocrine and Adrenal TumorsNeuroendocrine TumorsAdrenal TumorNCT04432532University of Pennsylvania999
已完成
不适用
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or GanglioneuroblastomaGanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaRegional NeuroblastomaStage 4 NeuroblastomaStage 4S NeuroblastomaNCT00904241Children's Oncology Group10,000
已完成
不适用
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant ChemotherapyAdvanced-stage Ovarian CancerNCT03491033Yonsei University250
进行中（未招募）
1 期
ADRB3 Signaling Pathway in Human Adipose TissueObesity, PrediabetesNCT05634174University of California, San Diego40
招募中
1 期
A Study on the Efficacy of GD2-CAR T Cells in the Treatment of NeuroblastomaNeuroblastomaNCT06684639The General Hospital of Western Theater Command30